AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25418542 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group (n=9)
Number of subjects: 19
Study 22658268 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT) + Specific Exercises (SE)
Number of subjects: 19
Study 22658268 — intervention group
Group type: COMPARATOR
Intervention: Specific Exercises (SE)
Number of subjects: 19
Study 21142633 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle modification with incorporation of the DASH diet
Number of subjects: 810
Study 21142633 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive lifestyle modification aimed at weight loss, increased exercise and dietary sodium reduction
Number of subjects: 810
Study 21142633 — intervention group
Group type: COMPARATOR
Intervention: Advice only
Number of subjects: 810
Study 18838727 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement collaborative (n = 22 hospitals)
Number of subjects: 4400
Study 18838727 — intervention group
Group type: COMPARATOR
Intervention: Comparative feedback report (control group, n = 22 hospitals)
Number of subjects: 4400
Study 15635615 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 in induced sputum from CF children
Number of subjects: 18
Study 15635615 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9/TIMP-1 molar ratio in CF children
Number of subjects: 18
Study 15635615 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 levels in CF children
Number of subjects: 18
Study 15635615 — intervention group
Group type: EXPERIMENTAL
Intervention: Sputum MMP-9 and TIMP-1 concentrations in CF children
Number of subjects: 18
Study 15635615 — intervention group
Group type: EXPERIMENTAL
Intervention: MMP-9 and TIMP-1 correlation with airway infection
Number of subjects: 18
Study 12075231 — intervention group
Group type: EXPERIMENTAL
Intervention: ThinPrep technique
Number of subjects: 209
Study 12075231 — intervention group
Group type: COMPARATOR
Intervention: Conventional smear technique
Number of subjects: 209
Study 9459075 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation task (expressing thoughts and feelings about entering college and formulating coping plans)
Number of subjects: 122
Study 9459075 — intervention group
Group type: EXPERIMENTAL
Intervention: Disclosure task (expressing thoughts and feelings only)
Number of subjects: 122
Study 9459075 — intervention group
Group type: COMPARATOR
Intervention: Control task (writing about trivial topics)
Number of subjects: 122
Study 7829604 — intervention group
Group type: EXPERIMENTAL
Intervention: GH treatment (0.2 IU/kg.week for 6 months)
Number of subjects: 22
Study 2371372 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive imipramine
Number of subjects: 14
Study 2371372 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 334471 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg flurbiprofen
Number of subjects: 24
Study 334471 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg phenylbutazone
Number of subjects: 24
Study 334471 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.1 g aspirin
Number of subjects: 24
Study 334471 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 24
Study 31916473 — intervention group
Group type: EXPERIMENTAL
Intervention: PRC-063 (16-hr multilayer-release methylphenidate)
Number of subjects: 375
Study 31916473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 375
Study 31898531 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma-Lyte
Number of subjects: 66
Study 31898531 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 66
Study 31104056 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D 2,000 IU tablet every other day for 12 weeks
Number of subjects: 130
Study 31104056 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 28540483 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 217
Study 28540483 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 217
Study 26608559 — intervention group
Group type: EXPERIMENTAL
Intervention: Stigma reduction intervention
Number of subjects: 1760
Study 23626006 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 30
Study 23626006 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated group)
Number of subjects: 30
Study 21304091 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI) plus optimal medical therapy (OMT)
Number of subjects: 2287
Study 21304091 — intervention group
Group type: COMPARATOR
Intervention: Optimal medical therapy (OMT) alone
Number of subjects: 2287
Study 19187813 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential Cognitive Therapy (RCT)
Number of subjects: 80
Study 19187813 — intervention group
Group type: EXPERIMENTAL
Intervention: Residential Interpersonal Psychotherapy (RIPT)
Number of subjects: 80
Study 19187813 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive variables (self‐focus, estimated probability and cost of negative social events, safety behaviors)
Number of subjects: 80
Study 19187813 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal variable (perceived acceptance by others)
Number of subjects: 80
Study 19187813 — intervention group
Group type: EXPERIMENTAL
Intervention: Social anxiety
Number of subjects: 80
Study 16957058 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid palatal expansion (RPE)
Number of subjects: 45
Study 16957058 — intervention group
Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 45
Study 15060509 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir (400 mg twice daily) and ritonavir (100 mg twice daily)
Number of subjects: 27
Study 15060509 — intervention group
Group type: EXPERIMENTAL
Intervention: amprenavir (600 mg twice daily) plus ritonavir (100 mg twice daily)
Number of subjects: 27
Study 15060509 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir (400 mg twice daily) and ritonavir (100 mg twice daily) plus additional ritonavir (100 mg twice daily)
Number of subjects: 27
Study 15060509 — intervention group
Group type: EXPERIMENTAL
Intervention: amprenavir (600 mg twice daily) plus ritonavir (200 mg twice daily)
Number of subjects: 27
Study 11456011 — intervention group
Group type: EXPERIMENTAL
Intervention: Lodoxamide 0.1% ophthalmic solution
Number of subjects: 95
Study 11456011 — intervention group
Group type: COMPARATOR
Intervention: Levocabastine 0.05% ophthalmic suspension
Number of subjects: 95
Study 9917590 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished stems
Number of subjects: 80
Study 9917590 — intervention group
Group type: EXPERIMENTAL
Intervention: Matte surfaced stems with metal centralizers
Number of subjects: 80
Study 9917590 — intervention group
Group type: EXPERIMENTAL
Intervention: Polished modular stems
Number of subjects: 80
Study 9917590 — intervention group
Group type: COMPARATOR
Intervention: Matte finish stems
Number of subjects: 80
Study 7805637 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 364
Study 7805637 — intervention group
Group type: EXPERIMENTAL
Intervention: Education
Number of subjects: 364
Study 7805637 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment
Number of subjects: 364
Study 7805637 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 364
Study 2968262 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF + MAP
Number of subjects: 289
Study 2968262 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP h.d.
Number of subjects: 289
Study 2968262 — intervention group
Group type: COMPARATOR
Intervention: MAP + CMF
Number of subjects: 289
Study 2968262 — intervention group
Group type: EXPERIMENTAL
Intervention: MAP
Number of subjects: 289
Study 1101844 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium carbonate
Number of subjects: 80
Study 1101844 — intervention group
Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 80
Study 31180819 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with oral tegafur-uracil
Number of subjects: 991
Study 31180819 — intervention group
Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 991
Study 28560194 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled suction pressure at 400 mmHg and operation time less than 75 s
Number of subjects: 300
Study 28560194 — intervention group
Group type: COMPARATOR
Intervention: Control group with suction pressure ranging from 400-500 mmHg
Number of subjects: 300
Study 25707402 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher 25-hydroxyvitamin D (25OHD) levels
Number of subjects: 1000
Study 25707402 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher 1,25-dihydroxyvitamin D (1,25(OH)2 D) levels
Number of subjects: 1000
Study 25707402 — intervention group
Group type: COMPARATOR
Intervention: Lowest 1,25(OH)2 D levels (8.70 to 51.60 pg/mL)
Number of subjects: 1000
Study 25707402 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustment of 1,25(OH)2 D data for 25OHD
Number of subjects: 1000
Study 25707402 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher 1,25(OH)2 D levels with BMD adjustment
Number of subjects: 1000
Study 25707402 — intervention group
Group type: EXPERIMENTAL
Intervention: 25OHD vs 1,25(OH)2 D
Number of subjects: 1000
Study 22077318 — intervention group
Group type: EXPERIMENTAL
Intervention: Detoxified Jatropha kernel meal (DJKM) diet (J(50))
Number of subjects: 180
Study 22077318 — intervention group
Group type: COMPARATOR
Intervention: Control diet (fish meal and wheat meal, without DJKM and SBM)
Number of subjects: 180
Study 22077318 — intervention group
Group type: EXPERIMENTAL
Intervention: Soybean meal (SBM) diet (S(50))
Number of subjects: 180
Study 22077318 — intervention group
Group type: EXPERIMENTAL
Intervention: DJKM diet (J(75))
Number of subjects: 180
Study 22077318 — intervention group
Group type: EXPERIMENTAL
Intervention: SBM diet (S(75))
Number of subjects: 180
Study 22077318 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 180
Study 21878826 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-question version of the Edinburgh Postpartum Depression Scale (EPDS)
Number of subjects: 195
Study 21878826 — intervention group
Group type: COMPARATOR
Intervention: Full EPDS
Number of subjects: 195
Study 21878826 — intervention group
Group type: COMPARATOR
Intervention: Provider impression of maternal depressive symptoms
Number of subjects: 195
Study 19622108 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal diclofenac 100 mg (Group 1, n = 19)
Number of subjects: 37
Study 19622108 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppository (Group 2, n = 18)
Number of subjects: 37
Study 19622108 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal diclofenac (Group 1)
Number of subjects: 37
Study 19622108 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group 2)
Number of subjects: 37
Study 17387026 — intervention group
Group type: EXPERIMENTAL
Intervention: Aceclofenac 100 mg twice daily
Number of subjects: 168
Study 17387026 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 1000 mg three times daily
Number of subjects: 168
Study 15596757 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 300 mg/day
Number of subjects: 338
Study 15596757 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin 600 mg/day
Number of subjects: 338
Study 15596757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 338
Study 15596757 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg/day and 600 mg/day)
Number of subjects: 338
Study 15596757 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 338
Study 11501247 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years program (experimental condition)
Number of subjects: 272
Study 11501247 — intervention group
Group type: COMPARATOR
Intervention: Regular Head Start program (control condition)
Number of subjects: 272
Study 9404176 — intervention group
Group type: EXPERIMENTAL
Intervention: nalbuphine 0.1 mg.kg‐1
Number of subjects: 90
Study 9404176 — intervention group
Group type: COMPARATOR
Intervention: pethidine 1 mg.kg‐1
Number of subjects: 90
Study 8424396 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin (M)
Number of subjects: 76
Study 8424396 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin plus high-dose medroxyprogesterone acetate (MMPA)
Number of subjects: 76
Study 2462473 — intervention group
Group type: EXPERIMENTAL
Intervention: Cadexomer iodine (CI)
Number of subjects: 42
Study 2462473 — intervention group
Group type: COMPARATOR
Intervention: Dextranomer
Number of subjects: 42
Study 31257067 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored therapy (PPI, amoxicillin, and clarithromycin for 7 days; PPI, amoxicillin, and levofloxacin for 10 days; PPI, amoxicillin, and metronidazole for 14 days)
Number of subjects: 526
Study 31257067 — intervention group
Group type: COMPARATOR
Intervention: Empirical therapy (PPI, amoxicillin, and clarithromycin for 7 days)
Number of subjects: 526
Study 28762476 — intervention group
Group type: EXPERIMENTAL
Intervention: Upadacitinib
Number of subjects: 0
Study 28762476 — intervention group
Group type: COMPARATOR
Intervention: Food effect
Number of subjects: 0
Study 28762476 — intervention group
Group type: COMPARATOR
Intervention: Manual ECG adjudication
Number of subjects: 0
Study 26509763 — intervention group
Group type: EXPERIMENTAL
Intervention: Gatifloxacin 0.3% (monotherapy)
Number of subjects: 204
Study 26509763 — intervention group
Group type: COMPARATOR
Intervention: Fortified cefazolin sodium 5% and tobramycin sulfate 1.3% (combination therapy)
Number of subjects: 204
Study 25327732 — intervention group
Group type: EXPERIMENTAL
Intervention: YAZ (drospirenone 3 mg and ethinylestradiol 20 µg)
Number of subjects: 187
Study 23752209 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentax AirWay Scope (AWS)
Number of subjects: 46
Study 23752209 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 46
Study 21038654 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenyanning (SYN) Decoction, one dose per day for 1 year
Number of subjects: 70
Study 21038654 — intervention group
Group type: COMPARATOR
Intervention: Losartan (50 mg per day for 1 year)
Number of subjects: 70
Study 18539767 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 27
Study 16158780 — intervention group
Group type: COMPARATOR
Intervention: Hydroxicine
Number of subjects: 40
Study 16158780 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast
Number of subjects: 40
Study 16158780 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast plus desloratadine
Number of subjects: 40
Study 16158780 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine
Number of subjects: 40
Study 12940665 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal resection
Number of subjects: 382
Study 12940665 — intervention group
Group type: EXPERIMENTAL
Intervention: Submucosal resection with lateral displacement
Number of subjects: 382
Study 12940665 — intervention group
Group type: COMPARATOR
Intervention: Turbinectomy
Number of subjects: 382
Study 12940665 — intervention group
Group type: COMPARATOR
Intervention: Laser cautery
Number of subjects: 382
Study 12940665 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery
Number of subjects: 382
Study 12940665 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy
Number of subjects: 382
Study 12799884 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 40
Study 12799884 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 40
Study 10407236 — intervention group
Group type: EXPERIMENTAL
Intervention: Changes in intake of various dietary lipids
Number of subjects: 71
Study 10407236 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical model for meta-analysis
Number of subjects: 71
Study 8565023 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium (NAP)
Number of subjects: 4138
Study 8565023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4138
Study 8565023 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 4138
Study 8565023 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 4138
Study 2646418 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% tetrapotassium peroxydiphosphate (PDP) solution administered as a subgingival irrigant
Number of subjects: 40
Study 2646418 — intervention group
Group type: COMPARATOR
Intervention: Placebo rinse similar to the test solution, but without PDP
Number of subjects: 40
Study 2646418 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% tetrapotassium peroxydiphosphate (PDP) solution
Number of subjects: 40
Study 913873 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone 50 mg/day
Number of subjects: 7
Study 913873 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone 100 mg/day
Number of subjects: 7
Study 913873 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone 200 mg/day
Number of subjects: 7
Study 913873 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone 400 mg/day
Number of subjects: 7
Study 913873 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone (all doses)
Number of subjects: 7
Study 913873 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone 50 and 100 mg/day
Number of subjects: 7
Study 913873 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylbutazone 200 and 400 mg/day
Number of subjects: 7
Study 31704518 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over the left inferior frontal gyrus combined with written naming/spelling therapy
Number of subjects: 30
Study 31704518 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS over the left inferior frontal gyrus combined with written naming/spelling therapy
Number of subjects: 30
Study 27876449 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin therapy (n = 27)
Number of subjects: 52
Study 27876449 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy (n = 25)
Number of subjects: 52
Study 26958015 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training for 12 weeks
Number of subjects: 80
Study 26958015 — intervention group
Group type: COMPARATOR
Intervention: No exercise training for 3 months
Number of subjects: 80
Study 23939631 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 0.1 mg/kg
Number of subjects: 31
Study 23939631 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 0.3 mg/kg
Number of subjects: 31
Study 23939631 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept 1 mg/kg
Number of subjects: 31
Study 23939631 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotatercept
Number of subjects: 31
Study 21291564 — intervention group
Group type: EXPERIMENTAL
Intervention: Centralised and specialised outpatient intervention program consisting of combined pharmacological and psychological intervention
Number of subjects: 0
Study 21291564 — intervention group
Group type: COMPARATOR
Intervention: Decentralised and non-specialised standard psychiatric treatment
Number of subjects: 0
Study 19524906 — intervention group
Group type: EXPERIMENTAL
Intervention: 200mg of oral iron tablets 3 times a day for 4 weeks
Number of subjects: 68
Study 16937978 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity resistance training (LI, n = 14, 40% of 1RM)
Number of subjects: 58
Study 16937978 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity resistance training (MI, n = 12, 60% of 1RM)
Number of subjects: 58
Study 16937978 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance training (HI, n = 14, 80% of 1RM)
Number of subjects: 58
Study 16937978 — intervention group
Group type: COMPARATOR
Intervention: Control group (C, n = 10)
Number of subjects: 58
Study 15571539 — intervention group
Group type: EXPERIMENTAL
Intervention: MSHO program (intervention)
Number of subjects: 0
Study 15571539 — intervention group
Group type: EXPERIMENTAL
Intervention: MSHO nursing home enrollees (intervention)
Number of subjects: 0
Study 15571539 — intervention group
Group type: COMPARATOR
Intervention: Control-in group (control)
Number of subjects: 0
Study 15571539 — intervention group
Group type: COMPARATOR
Intervention: Control-out group (control)
Number of subjects: 0
Study 11158764 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemifloxacin (320 mg)
Number of subjects: 12
Study 11158764 — intervention group
Group type: COMPARATOR
Intervention: Trovafloxacin (200 mg)
Number of subjects: 12
Study 9034243 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleic acid rich diet
Number of subjects: 22
Study 9034243 — intervention group
Group type: COMPARATOR
Intervention: Linoleic acid rich diet
Number of subjects: 22
Study 9034243 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 22
Study 8509683 — intervention group
Group type: EXPERIMENTAL
Intervention: diclofenac sodium 0.1% eye drops (Voltaren Ophthalmic)
Number of subjects: 50
Study 8509683 — intervention group
Group type: COMPARATOR
Intervention: prednisolone acetate 1.0% eye drops (Pred Forte)
Number of subjects: 50
Study 29092630 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle enhanced home visiting curriculum
Number of subjects: 54
Study 29092630 — intervention group
Group type: COMPARATOR
Intervention: Standard home visiting curriculum (control)
Number of subjects: 54
Study 27541556 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured cancer survivorship care plan (SCP) transition visit
Number of subjects: 34
Study 27541556 — intervention group
Group type: COMPARATOR
Intervention: SCP transition visit coupled with a coordinated follow‐up visit from the primary care provider (PCP)
Number of subjects: 34
Study 24980063 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-week programme (n=45)
Number of subjects: 87
Study 24980063 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=42)
Number of subjects: 87
Study 22264371 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia for eight days, target temperature of 35.0°C achieved by endovascular catheters.
Number of subjects: 50
Study 22264371 — intervention group
Group type: COMPARATOR
Intervention: Conventional temperature management.
Number of subjects: 50
Study 22264371 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic hypothermia
Number of subjects: 50
Study 22264371 — intervention group
Group type: COMPARATOR
Intervention: Conventional temperature management
Number of subjects: 50